Hairy Cell Leukemia

Showing NaN - NaN of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients Previously Treated WithMustang Bio CAR-T Cell

Enrolling by invitation
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • +10 more
  • Prior MB-102 CAR-T cell investigational product.
  • Prior MB-106 CAR-T cell investigational product.
  • Duarte, California
  • +4 more
Dec 8, 2022

Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
Feb 7, 2022

Collecting and Storing Malignant, Borderline Malignant

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +191 more
Jul 17, 2018